Annual Accounts Receivable
N/A
December 31, 2023
Summary
- TENX annual accounts receivable is not available.
Performance
TENX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- TENX quarterly accounts receivable is not available.
Performance
TENX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TENX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
TENX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Tenax Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $0.00(-100.0%) |
| Jun 2018 | - | $39.30 K(0.0%) |
| Mar 2018 | - | $39.30 K(-21.7%) |
| Dec 2017 | $50.20 K(-30.9%) | $50.20 K(+104.1%) |
| Sep 2017 | - | $24.60 K(0.0%) |
| Jun 2017 | - | $24.60 K(0.0%) |
| Mar 2017 | - | $24.60 K(-66.1%) |
| Dec 2016 | $72.60 K(+47.0%) | $72.60 K(0.0%) |
| Sep 2016 | - | $72.60 K(+195.1%) |
| Jun 2016 | - | $24.60 K(-50.1%) |
| Mar 2016 | - | $49.30 K(-42.9%) |
| Dec 2015 | $49.40 K(-35.4%) | - |
| Oct 2015 | - | $86.30 K(-12.5%) |
| Jul 2015 | - | $98.60 K(+28.9%) |
| Apr 2015 | $76.50 K(+110.2%) | $76.50 K(+18.2%) |
| Jan 2015 | - | $64.70 K(+77.7%) |
| Oct 2014 | - | $36.40 K(0.0%) |
| Jul 2014 | - | $36.40 K(0.0%) |
| Apr 2014 | $36.40 K | $36.40 K(-31.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2014 | - | $53.10 K(-18.1%) |
| Oct 2013 | - | $64.80 K(-33.1%) |
| Jul 2013 | - | $96.80 K(-78.3%) |
| Apr 2013 | $445.20 K(+3222.4%) | $445.20 K(+3173.5%) |
| Jan 2013 | - | $13.60 K(-20.9%) |
| Oct 2012 | - | $17.20 K(-27.1%) |
| Jul 2012 | - | $23.60 K(+76.1%) |
| Apr 2012 | $13.40 K(-90.4%) | $13.40 K(-30.9%) |
| Jan 2012 | - | $19.40 K(+155.3%) |
| Oct 2011 | - | $7600.00(-73.0%) |
| Jul 2011 | - | $28.10 K(-79.8%) |
| Apr 2011 | $138.90 K(+92.6%) | $138.90 K(+1680.8%) |
| Jan 2011 | - | $7800.00(-64.7%) |
| Oct 2010 | - | $22.10 K(+256.5%) |
| Jul 2010 | - | $6200.00(-91.4%) |
| Apr 2010 | $72.10 K(+123.2%) | $72.10 K(-9.5%) |
| Jan 2010 | - | $79.70 K(+54.5%) |
| Oct 2009 | - | $51.60 K(+18.9%) |
| Jul 2009 | - | $43.40 K(+34.4%) |
| Apr 2009 | $32.30 K | $32.30 K |
FAQ
- What is the all time high annual accounts receivable for Tenax Therapeutics?
- What is the all time high quarterly accounts receivable for Tenax Therapeutics?
What is the all time high annual accounts receivable for Tenax Therapeutics?
Tenax Therapeutics all-time high annual accounts receivable is $445.20 K
What is the all time high quarterly accounts receivable for Tenax Therapeutics?
Tenax Therapeutics all-time high quarterly accounts receivable is $445.20 K